New Vaccine Research Highlights Infectious Disease Advances Ahead of IDWeek 2026
Pfizer will present 57 research abstracts at IDWeek 2026, highlighting vaccine research…
WHO Prequalifies Multi-Dose RSV Vaccine to Protect More Infants Globally
WHO prequalifies a multi-dose maternal RSV vaccine vial, making infant protection more…
Global Phase 1b Trial Advances New RSV Preventive Antibody
SK bioscience submits a global Phase 1b CTA for RSM01, an RSV…
New Evidence Suggests One RSV Immunization May Protect Babies for Two Years
A landmark study from Spain shows that a single RSV immunization with…
Beyfortus Approved in China: Could This Be the Answer to Preventing RSV in Infants?
China- January 2024- China has approved Beyfortus (nirsevimab), a newly developed long-acting…
